TOBRAMYCIN SULFATE – tobramycin 1.2 gram solution for injection

XGen Pharmaceuticals DJB Inc.

skin and skin structure Klebsiella infection; synergy for P. aeruginosa infection in cystic fibrosis; Enterobacter pneumonia; Klebsiella pneumoniae septicemia; Enterobacter complicated UTI; Staphylococcus aureus complicated UTI; Serratia complicated UTI; E. coli peritonitis; Klebsiella pneumoniae osteomyelitis; Pseudomonas aeruginosa septicemia; E. coli septicemia; Serratia pneumonia; nosocomial bacterial pneumonia; Enterobacter peritonitis; Klebsiella pneumonia; Klebsiella complicated UTI; Staphylococcus aureus skin and skin structure infection; Providencia complicated UTI; Escherichia coli pneumonia; Pseudomonas respiratory tract infxn in cystic fibrosis; complicated E. coli UTI; pediatric fever without a source; skin and skin structure E. coli infection; bacterial infection; bacterial sepsis; synergy for staphylococcal infection; bone infection; Pseudomonas aeruginosa osteomyelitis; bacterial meningitis; complicated UTI with Pseudomonas aeruginosa; Enterobacter osteomyelitis; Pseudomonas aeruginosa pneumonia; neonatal meningitis; febrile neutropenic patient presumed infection treatment; synergy for nosocomial pneumonia due to P. aeruginosa; synergy for neonatal meningitis; skin and skin structure Proteus infection; Staphylococcus aureus osteomyelitis; gram-negative aerobic bacillary pneumonia; skin and skin structure P. aeruginosa infection; complicated Proteus UTI; Citrobacter complicated UTI; Proteus mirabilis osteomyelitis; skin and skin structure Enterobacter infection; E. coli osteomyelitis; sepsis of newborn; staphylococcal pneumonia; complicated bacterial infection of urinary tract; Klebsiella pneumoniae peritonitis; synergy for bacterial meningitis

Controlled Room Temp (20-25°C)